The Canadian Technology Accelerator in Boston (CTA@Boston) is an award-winning immersion program that drives growth for small and medium sized Canadian companies. Operated by the Consulate General of Canada in Boston, the program has assisted over 77 Canadian companies since its founding in 2013 with its unique business acceleration services that help companies commercialize or scale their business in the US market.
Paulina Hill is a healthcare investor who has expertise in biotechnology, molecular biology, cell culture and entrepreneurship.
Venture Capital Chemistry Technology Transfer Biochemistry Lifesciences Molecular Biology
Consultant, Board Member and Advisor
Paul Jansen is an experienced pharmaceutical industry professional with expertise in drug and biologics device development.
Biotechnology Pharmaceutical Industry Drug Development Biologics Device Development Product Launch
Avak Kahvejian is an expert in conceiving and launching internally generated platform companies and leveraging new biological mechanisms.
Biotechnologies Design Biology Technology Biological Mechanisms
Dr. Jeff Karp is a leading researcher in the fields of drug delivery, medical devices, stem cell therapeutics, and tissue adhesives.
Biomaterials Stem Cell Therapeutics Drug Delivery Medical Devices Biomedical Engineering
Angel Investor and Board Member
Henry Kay is on the Boards of Directors of several Life science companies in the US and Canada and is an active angel investor.
Commercialization Medical Devices Investing Venture Capital Strategy
VP of Market Access and HEOR
Robert Kemp is an expert at developing value strategies using clinical and economic information.
Health Plans Health Informatics Medical Device Outcomes Research Strategic Leadership Strategy Development Health Economics Patient & Institutional Research Biotech/Pharmaceutical Diagnostic Health Providers
George Kenney is an expert in building technology development teams in advanced materials and devices.
Biomedical Engineering Entrepreneurship Materials Science Product Development
Principal Product Manager
Mona Khabazan is an expert in product initiatives and business market strategies to drive revenue growth.
Strategic Innovation Business Marketing Strategies Consulting Enterprise Software Agile Methodologies Strategy Product Initiatives
Chief of Otolaryngology Division
Ayesha Khalid is a practicing clinician who pioneered groundbreaking research in sinus inflammation and clinical outcomes in sinus disease.
Digital Health Clinical Trials System Analysis Clinician Surgery Innovator BD Otolaryngology Stem Medical Education
VP of Business Development
Don Khoury is an expert in market research, sales, and business strategy.
Home Healthcare Sales Strategy